An Overview of Helicobacter pylori Infection

Methods Mol Biol. 2021:2283:1-14. doi: 10.1007/978-1-0716-1302-3_1.

Abstract

Helicobacter pylori (H. pylori) represents one of the most widespread bacterial infections globally. Infection causes chronic gastritis and increases the risk of peptic ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. The pioneering discovery of H. pylori by Marshall and Warren in the early 1980s has initiated fervent research into H. pylori as a pathogen ever since. This chapter aims to provide an overview of our understanding of H. pylori infection and its management, with a focus on current options for diagnosis, the challenges associated with H. pylori eradication, and the need for alternative therapeutic strategies based on furthering our understanding of host: H. pylori interactions.

Keywords: Antibiotic resistance; Bacteria; Diagnosis; Helicobacter pylori; Immune responses; Infection; Inflammation; Treatment; Vaccine; Virulence factor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Vaccines / pharmacology
  • Bacterial Vaccines / therapeutic use
  • Disease Management
  • Drug Resistance, Bacterial / drug effects
  • Helicobacter Infections / complications
  • Helicobacter Infections / diagnosis*
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects
  • Helicobacter pylori / pathogenicity*
  • Humans

Substances

  • Anti-Bacterial Agents
  • Bacterial Vaccines